All In Biotech

Drug Trial Radar · NCT02522481

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141

A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease

Last checked: Nov 20, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

175

Actual

Start

Sep 24, 2015

Primary completion

Nov 7, 2017

Study completion Feb 25, 2018

Sponsor

Lead sponsor
Bracco Diagnostics, IncIndustry
Sponsor type
Industry
First posted
Aug 13, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to assess the safety and efficacy of Lumason-enhanced dobutamine stress echo (CE-DSE) in subjects having a suboptimal left ventricular endocardial border delineation (LV EBD) at rest and who were scheduled for coronary angiography.

Conditions

  • Coronary Artery Disease

Interventions

  • LumasonDrug

    Lumason (sulfur hexafluoride-type A microspheres) an ultrasound contrast agent was administered as 2 single 2-mL IV injections during rest and stress echocardiography

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity and Specificity for Detection or Exclusion of Coronary Artery Disease (CAD)Time frame: Participants were followed until they had coronary angiography or up to 6 months post dose to collect clinical information on cardiac events if no coronary angiography were performed
  2. Reader-Specific Percentages of Participants Identified as Having a Critical Shift From Suboptimal to Optimal Echocardiographic ImagesTime frame: Participants were followed until they had coronary angiography or up to 6 months post dose to collect clinical information on cardiac events if no coronary angiography was performed

Locations

17 sites in 4 countries. Site status is shown where the registry gives one.

  • Sarver Heart Center, University of Arizona

    Tucson, Arizona

  • University of California San Diego

    La Jolla, California

  • Interventional Cardiology Medical Group, Inc.

    West Hills, California

  • Cardiology Physicians, PA

    Newark, Delaware

  • Community Heart and Vascular Community Hospital East

    Indianapolis, Indiana

  • St. Luke's Mid-America Heart Institute

    Kansas City, Missouri

  • North Kansas City Hospital

    North Kansas City, Missouri

  • Morristown Medical Center

    Morristown, New Jersey

  • The Institute for Clinical Research Holy Name Medical Center

    Teaneck, New Jersey

  • Mount Sinai Medical Center

    New York, New York

  • Mazankowski Alberta Heart Institute, University of Alberta Hospital

    Edmonton, Alberta, Canada

  • Medizinische Klinik m.S. Kardiologie und Angiologie, Charité Universitätsmedizin Berlin

    Berlin, Germany

  • Klinikum Lünen, St. Marien-Hospital GmbH

    Lünen, Germany

  • Universitätsmedizin Mainz

    Mainz, Germany

  • Kardiologie Klinik Dr. Müller GmbH, Peter Osypka Heart Center

    Munich, Germany

  • Azienda Ospedaliera Universitaria Parma

    Parma, Italy

  • Azienda Policlinico Umberto I Università degli Studi di Roma La Sapienza

    Rome, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.